Aquatic Capital Management LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1803916 CHICAGO, IL

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,193,286

-$387,200 QoQ

Shares Held

19,754

-33.4% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#129

of 299 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $144,356,048 across 88 Biotechnology names. RYTM ranks #17 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	32,577	$20,313,062
2	CYTK	Cytokinetics Inc	125,090	$10,656,417
3	TVTX	Travere Therapeutics, Inc.	157,710	$8,959,505
4	ARGX	Argenx SE	7,697	$7,141,045
5	PTCT	Ptc Therapeutics, Inc.	83,470	$6,808,647
6	TGTX	Tg Therapeutics, Inc.	99,530	$5,468,178
7	ALNY	Alnylam Pharmaceuticals, Inc.	15,480	$4,659,944
8	MIRM	Mirum Pharmaceuticals, Inc.	36,670	$4,292,956

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,193,286	19,754	-33.4%	Shares	Sole	2026-08-14
2026-03-31	$2,580,486	29,671	-30.2%	Shares	Sole	2026-05-15
2025-09-30	$4,291,065	42,490	+974.9%	Shares	Sole	2025-11-14
2025-06-30	$249,790	3,953	-90.5%	Shares	Sole	2025-08-14
2025-03-31	$2,196,983	41,476	+349.7%	Shares	Sole	2025-05-15
2024-12-31	$516,303	9,223	+7.2%	Shares	Sole	2025-02-14
2024-03-31	$372,638	8,600	+177.4%	Shares	Sole	2024-05-15
2023-09-30	$71,067	3,100	+34.8%	Shares	Sole	2023-11-14
2022-06-30	$9,545	2,300	+666.7%	Shares	Sole	2022-08-15
2022-03-31	$3,456	300	-92.5%	Shares	Sole	2022-05-16
2021-12-31	$39,920	4,000	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.